Merck KGaA Appoints Allan Gabor as Managing Director in China

By Marc Navarro GonzalezFeaturesDow Jones Newswires

Merck KGaA (MRK.XE) said on Tuesday that Allan Gabor will succeed Alasdair Jelfs as managing director for the company in China as of Feb. 1, 2018.

The German company said Mr. Gabor would also take over operational responsibility for the performance materials business in China.

Continue Reading Below

Additionally, Mr. Gabor will become a permanent member of the performance materials leadership team, Merck KGaA said.

Mr. Jelfs take up duties at company headquarters in Darmstadt, Germany, the company said.

Mr. Gabor joined Merck KGaA in 2013, and is currently head of the biopharma business in Asia, including China. Prior to joining the company, Mr. Gabor was head of Pfizer in China.

Write to Marc Navarro Gonzalez at marc.navarrogonzalez@dowjones.com

(END) Dow Jones Newswires

December 12, 2017 05:02 ET (10:02 GMT)